Atlas Trials

A Multicenter, Single Arm Study to Evaluate the Preliminary Efficacy and Safety Profile of Inavolisib in Previously Treated Pancreatic Ductal Adenocarcinoma Patients

Clinical trial NCT07694973 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07694973
Sponsor
Fudan University
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Pancreatic Ductal Adenocarcinoma (PDAC)
Start date
2026-08-29
Primary completion
2028-06-29
Enrollment
62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.